Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study - Marabelle, A; Le, DT; Ascierto, PA (J Clin Oncol, 2020)